Adam Barczyk

3.4k total citations · 1 hit paper
80 papers, 2.0k citations indexed

About

Adam Barczyk is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Emergency Medical Services. According to data from OpenAlex, Adam Barczyk has authored 80 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pulmonary and Respiratory Medicine, 30 papers in Physiology and 10 papers in Emergency Medical Services. Recurrent topics in Adam Barczyk's work include Chronic Obstructive Pulmonary Disease (COPD) Research (35 papers), Asthma and respiratory diseases (23 papers) and Respiratory Support and Mechanisms (11 papers). Adam Barczyk is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (35 papers), Asthma and respiratory diseases (23 papers) and Respiratory Support and Mechanisms (11 papers). Adam Barczyk collaborates with scholars based in Poland, Italy and United Kingdom. Adam Barczyk's co-authors include Władysław Pierzchała, Ewa Sozańska, Ian M. Adcock, Gaetano Caramori, Peter J. Barnes, Onn Min Kon, Borja G. Cosío, Kazuhiro Ito, Shizu Hayashi and Misako Ito and has published in prestigious journals such as New England Journal of Medicine, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Adam Barczyk

72 papers receiving 2.0k citations

Hit Papers

Decreased Histone Deacetylase Activity in Chronic Obstruc... 2005 2026 2012 2019 2005 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease
    2005 734 citations Kazuhiro Ito, Misako Ito et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Barczyk Poland 17 1.1k 898 476 469 307 80 2.0k
Raimundas Sakalauskas Lithuania 22 1.1k 1.0× 893 1.0× 325 0.7× 433 0.9× 171 0.6× 110 2.0k
Vera M. Keatings Ireland 16 2.2k 2.0× 1.7k 1.9× 315 0.7× 357 0.8× 377 1.2× 20 3.0k
Yoshiaki Minakata Japan 25 900 0.8× 718 0.8× 261 0.5× 226 0.5× 63 0.2× 89 1.6k
S. T. Holgate United Kingdom 15 957 0.9× 1.2k 1.3× 239 0.5× 339 0.7× 91 0.3× 26 2.0k
Krzysztof Sładek Poland 23 1.0k 1.0× 1.5k 1.6× 191 0.4× 272 0.6× 86 0.3× 117 2.3k
Mario Del Donno Italy 16 1.4k 1.3× 1.2k 1.3× 146 0.3× 175 0.4× 193 0.6× 27 1.8k
M Fujimura Japan 29 1.6k 1.5× 1.6k 1.7× 304 0.6× 189 0.4× 191 0.6× 128 2.9k
Yuma Hoshino Japan 25 1.3k 1.2× 574 0.6× 544 1.1× 183 0.4× 107 0.3× 48 2.1k
Masaya Takemura Japan 31 2.1k 2.0× 1.4k 1.6× 264 0.6× 230 0.5× 160 0.5× 120 3.0k
Jessica Jones Australia 25 465 0.4× 486 0.5× 382 0.8× 634 1.4× 68 0.2× 32 1.8k

Countries citing papers authored by Adam Barczyk

Since Specialization
Citations

This map shows the geographic impact of Adam Barczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Barczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Barczyk more than expected).

Fields of papers citing papers by Adam Barczyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Barczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Barczyk. The network helps show where Adam Barczyk may publish in the future.

Co-authorship network of co-authors of Adam Barczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Barczyk. A scholar is included among the top collaborators of Adam Barczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Barczyk. Adam Barczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Antczak, Adam, Adam Barczyk, Robert Flisiak, et al.. (2025). RSV prevention in adults: consensus of experts of Polish scientific societies. Family Medicine & Primary Care Review. 27(3). 353–359.
2.
3.
West, Alex, Nazia Chaudhuri, Adam Barczyk, et al.. (2023). Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose–response trial. Thorax. 78(9). 882–889. 35 indexed citations
4.
Barczyk, Adam, Marek Barczyk, Szczepan Cofta, et al.. (2023). Efficacy of oral amantadine among patients hospitalised with COVID-19: A randomised, double-blind, placebo-controlled, multicentre study. Respiratory Medicine. 212. 107198–107198. 6 indexed citations
5.
Swinarew, Andrzej, Grzegorz Brożek, Halina Batura‐Gabryel, et al.. (2023). May noninvasive mechanical ventilation and/ or continuous positive airway pressure increase the bronchoalveolar lavage salvage in patients with pulmonary diseases? Randomized clinical trial - Study protocol. Advances in Medical Sciences. 68(2). 482–490. 1 indexed citations
6.
Kozłowski, Michał, et al.. (2022). Mallampati Score Is an Independent Predictor of Active Oxygen Therapy in Patients with COVID-19. Journal of Clinical Medicine. 11(11). 2958–2958.
7.
Górska, Katarzyna, Marta Maskey‐Warzęchowska, Adam Białas, et al.. (2022). Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland. Therapeutic Advances in Chronic Disease. 13. 374166558–374166558. 2 indexed citations
8.
Skoczyński, Szymon, et al.. (2022). Post-tracheostomy complications: respiratory failure caused by authologic foreign body—case report. Annals of Palliative Medicine. 11(8). 2761–2767. 1 indexed citations
9.
Valipour, Arschang, С. Н. Авдеев, Adam Barczyk, et al.. (2021). Therapeutic Success of Tiotropium/Olodaterol, Measured Using the Clinical COPD Questionnaire (CCQ), in Routine Clinical Practice: A Multinational Non-Interventional Study. International Journal of COPD. Volume 16. 615–628. 4 indexed citations
10.
11.
Miravitlles, Marc, Vladimír Koblížek, Cristina Esquinas, et al.. (2019). Determinants of CAT (COPD Assessment Test) scores in a population of patients with COPD in central and Eastern Europe: The POPE study. Respiratory Medicine. 150. 141–148. 16 indexed citations
12.
Pierzchała, Władysław, et al.. (2019). End-of-life care for patients with advanced lung cancer and chronic obstructive pulmonary disease – survey among Polish pulmonologists. Polskie Archiwum Medycyny Wewnętrznej. 129(4). 242–252. 4 indexed citations
13.
Ruggeri, Paolo, et al.. (2019). D-dimer value in the diagnosis of pulmonary embolism—may it exclude only?. Journal of Thoracic Disease. 11(3). 664–672. 19 indexed citations
14.
Skoczyński, Szymon, et al.. (2019). Is It Possible to Predict Whether BAL Salvage Is Going to Be Diagnostic?. Advances in respiratory medicine. 87(1). 20–25. 3 indexed citations
15.
Kania, Aleksander, Rafał Krenke, Krzysztof Kuziemski, et al.. (2018). Distribution and characteristics of COPD phenotypes – results from the Polish sub-cohort of the POPE study. International Journal of COPD. Volume 13. 1613–1621. 22 indexed citations
16.
Stefano, Antonino Di, Gaetano Caramori, Adam Barczyk, et al.. (2014). Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD.. IrInSubria (University of Insubria). 98 indexed citations
17.
Barczyk, Adam, et al.. (2011). Eotaxin, but not IL-8, is increased in upper and lower airways of allergic rhinitis subjects after nasal allergen challenge. Allergy and Asthma Proceedings. 32(3). 230–238. 15 indexed citations
18.
Pierzchała, Władysław, Adam Barczyk, Dorota Górecka, Paweł Śliwiński, & J Zieliński. (2010). [Recommendations of Polish Society of Lung Diseases about diagnosis and therapy of chronic obstructive pulmonary disease (COPD)].. PubMed. 78(5). 318–47. 6 indexed citations
19.
Barczyk, Adam, et al.. (2006). [Nasal provocation tests in the diagnosis of allergic rhinitis].. PubMed. 59(5-6). 396–402. 1 indexed citations
20.
Ito, Kazuhiro, Misako Ito, W. Mark Elliott, et al.. (2005). Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease. New England Journal of Medicine. 352(19). 1967–1976. 734 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raimundas Sakalauskas Breakdown of academic impact, for papers by Vera M. Keatings Breakdown of academic impact, for papers by Yoshiaki Minakata Breakdown of academic impact, for papers by S. T. Holgate Breakdown of academic impact, for papers by Krzysztof Sładek Breakdown of academic impact, for papers by Mario Del Donno Breakdown of academic impact, for papers by M Fujimura Breakdown of academic impact, for papers by Yuma Hoshino Breakdown of academic impact, for papers by Masaya Takemura Breakdown of academic impact, for papers by Jessica Jones
Rankless by CCL
2026